5-HT 1B/D receptor agonist, SKF99101H, induces locomotor hyperactivity in the guinea pig

Abstract

Previous studies in guinea pigs have shown that while a serotonin 5-HT 1B/D receptor agonist, GR46611, does not induce locomotor activation when given alone, it markedly enhances the locomotor response to selective 5-HT 1A receptor agonists, 8-OH-DPAT and buspirone. In these studies, we found that another 5-HT 1B/D agonist, 3-(2-dimethylaminoethyl)-4-chloro-5-propoxyindole hemifumarate (SKF99101H), significantly elevated locomotor activity in guinea pigs when given alone. We assessed the relative contribution of 5-HT1 1A and 5-HT 1B/D receptors in the mediation of this effect. Activity was measured by photobeam interrupts in opaque Perspex cylinders linked to a computer. SKF99101H (20 mg/kg s.c.) significantly increased the locomotor activity in guinea pigs. The locomotor stimulant effect of SKF99101H (20 mg/kg s.c) was reversed by the selective 5-HT 1B/D receptor antagonist N-[4-methoxy-3-(4-methyl-1-piperazinyl)phenyl]-2′-methyl-4′-(5-methyl-1,2,4-oxadiazol-3-yl)[1,1biphenyl]4-carboxamide (GR127935; 0.06–0.25 mg/kg s.c.). The 5-HT 1A receptor antagonist N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]- N-(2-pyridinyl) cyclohexanecarboxamide trihydrochloride (WAY100635; 0.05–0.25 mg/kg s.c.), slightly but significantly attenuated the hyperactivity induced by SKF99101H. These findings suggest that 5-HT 1B/D receptor agonists may require concomitant activation of 5-HT 1A receptors to induce locomotor activity in guinea pigs. The 5-HT 2A receptor antagonist 6[2-[4-[bis(4-fluorophenyl)methylene]-1-piperidinyl]-ethyl]-7-methyl-5H-thiazol[3,2-a]pyrimidin-5-one (ritanserin) had no effect on SKF99101H-induced hyperactivity, suggesting that these receptors are not involved in the mediation of SKF99101H-induced hyperactivity. SKF99101H-induced hyperactivity was significantly attenuated by the D 1 dopamine receptor antagonist SCH 23390 (0.005–025 mg/kg), but not by the D 2 dopamine receptor antagonist raclopride (0.25–1.0 mg/kg), possibly suggesting the selective involvement of D 1 dopaminergic receptors in the mediation of the stimulant actions of the 5-HT 1B/D agonist.